Biotech · Private company
Kolon TissueGene, Inc.
Track this companyFree. Adds Kolon TissueGene, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- TG-CPhase 3 · Degenerative OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the KneePHASE3 · COMPLETED · started Dec 9, 2021ClinicalTrials.gov NCT03291470 · fetched Nov 12, 2026
- A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the KneePHASE3 · ACTIVE_NOT_RECRUITING · started Oct 30, 2018ClinicalTrials.gov NCT03203330 · fetched Nov 12, 2026